COVID-19 (Coronavirus Disease 2019). COVID-19, virus identified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: COVID-19 patients with severe acute pneumonia hospitalized in the ward before requiring ICU admission Positive PCR test result Respiratory rate =30 per minute Oxygen saturation = 93% Fraction of inspired oxygen (FIO2) = 300 mmHg Progression of lung lesions by more than 50% within 24-48 hours in the chest CT-scans 30 to 70-year-old men and women
Exclusion criteria
Exclusion criteria: A history of cancer A history of benign tumors Pregnancy A history of photosensitivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of lung involvement on CT-scan or chest x-ray. Timepoint: Before the intervention and after the last session of laser acupuncture treatment. Method of measurement: CT-scanner and portable x-ray unit.;IL-6 serum levels. Timepoint: Before the intervention and after the last session of laser acupuncture treatment. Method of measurement: IL-6 ELISA kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Respiratory rate per minute. Timepoint: Before the intervention and after the each session of laser acupuncture treatment. Method of measurement: Counting the number of breaths in one minute.;Heart rate. Timepoint: Before the intervention and after the last session of laser acupuncture treatment. Method of measurement: Electrocardiogram.;Body temperature. Timepoint: Before the intervention and after the last session of laser acupuncture treatment. Method of measurement: Thermometer.;Oxygen saturation level. Timepoint: Before the intervention and after the last session of laser acupuncture treatment. Method of measurement: Pulse oxymeter.;Partial pressure of oxygen (PaO2)/Fraction of inspired O2 (FiO2). Timepoint: Before the intervention and after the last session of laser acupuncture treatment. Method of measurement: ABG (arterial-blood gas) test.;WBC count. Timepoint: Before the intervention and after the last session of laser acupuncture treatment. Method of measurement: Measuring the number of WBCs in the patients' blood samples. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences